Patents Assigned to Metatron
-
Publication number: 20130160490Abstract: A charm includes a connecting portion including a stem having a first end and an opposing second end, a stop located at the first end of the stem and a base located at the opposing second end of the stem. The stop is substantially oval in shape, and the connecting portion is made of a bendable material. The charm also includes a decorative portion secured to the base of the connecting portion. The charm is attachable to an object including a hole such that the stem is located in the hole, the stop is located on a first side of the object, and the decorative portion is located on an opposing second side of the object.Type: ApplicationFiled: November 9, 2012Publication date: June 27, 2013Applicant: METATRON JAPAN CORPORATIONInventor: Metatron Japan Corporation
-
Patent number: 8132561Abstract: Provided in a gas-feed system, in particular a system for supplying methane or hydrogen to an internal-combustion engine, is an electronic pressure-reducer or pressure-regulator unit, integrated in which are both a pressure-reducing valve for reducing the pressure of the gas coming from the fuel tank to a value suitable for supplying a distribution manifold or rail and a modulating solenoid valve that functions as modulator of the degree of pressure reduction performed by the pressure-reducing valve. Likewise made in the body of said unit are passages that provide the communications of said valves with one another and of each of said valves with the inlet and the outlet for the gas in said unit. Furthermore, the unit incorporates an electronic control module for controlling the modulating solenoid valve.Type: GrantFiled: October 31, 2007Date of Patent: March 13, 2012Assignee: METATRON S.r.l.Inventors: Filippo Audisio, Massimiliano Bagnato, Riccardo Groppo, Alberto Manzone, Damiano Micelli, Paolo Reggio
-
Patent number: 6700953Abstract: The present invention measures the quality of a transmission channel by utilizing voice recognition technology in a novel manner.Type: GrantFiled: September 2, 2000Date of Patent: March 2, 2004Assignee: Metatron Technologies, Inc.Inventors: Brett Pierre Maurer, Michael Jacob Schechter, Curtis Fred Elsasser
-
Patent number: 6600306Abstract: The invention concerns a method and apparatus for monitoring the polar compound content of a liquid bath disposed within a cooking vat to insure the liquid bath remains suitable for human consumption while in use. The invention thus teaches the use of a capacitive probe configured take an initial measurement of the dielectric constant of the liquid bath and thereby define a shutdown criterion. The dielectric constant is then continuously measured during subsequent heating cycles and compared with the initial measurement. A shutdown procedure is triggered when the difference between the initial measurement and subsequent measurements reach a predetermined threshold defined by the shutdown criteria. In this manner, the polar content of the cooking vat is continuously and automatically monitored such that operator supervision is not necessary.Type: GrantFiled: September 28, 2001Date of Patent: July 29, 2003Assignee: MetatronInventors: Christian Pernot, Denis Le Henaff
-
Patent number: 6331610Abstract: The present invention relates to select peptides of the carboxy terminal and aminoterminal portion of the beta unit of hCG and pharmaceutically acceptable derivatives thereof that can be used for controlling retroviral, e.g., human immunodeficiency virus (BV infections. The invention comprises a method in vitro as well as in vivo for prevention and/or treatment of acquired immune deficiency syndrome (AIDS) at pharmacological doses of beta hCG-derived peptides and pharmaceutically acceptable derivatives thereof which are sufficient to exert an anti-HIV effect for a sufficient period of time.Type: GrantFiled: August 7, 1997Date of Patent: December 18, 2001Assignee: Metatron, Inc.Inventor: Aldar S. Bourinbaiar
-
Patent number: 6001808Abstract: The present invention relates to a method of using antibiotic gramicidin for the therapy and prevention of herpes virus infections. Gramicidin is also useful in suppressing sperm motility without affecting its viability and may thus be used as an active ingredient of topical contraceptive formulations either alone or in combination with chelating agents such as EDTA or salts thereof.Type: GrantFiled: August 15, 1997Date of Patent: December 14, 1999Assignee: Metatron, Inc.Inventor: Aldar S. Bourinbaiar
-
Patent number: 5837729Abstract: The present invention relates to the use of acetaminophen (Tylenol) and derivatives thereof which can be used to inhibit the growth, replication and elaboration of the human immunodeficiency virus (HIV). The present invention comprises in vitro as well as in vivo methods for the prevention and/or treatment of HIV infections and acquired immune deficiency syndrome (AIDS), at doses of acetaminophen or its derivatives which are effective to inhibit the replication, growth and/or elaboration of HIV.Type: GrantFiled: April 26, 1996Date of Patent: November 17, 1998Assignee: Metatron, Inc.Inventor: Aldar S. Bourinbaiar
-
Patent number: 5811390Abstract: Described is a method for inhibiting the growth and/or replication of human immunodeficiency virus (HIV) in human patients. The invention relates to the unexpected activity of human chorionic gonadotropin (hCG) and in particular, to the beta chain of hCG (beta hCG) in controlling a human immunodeficiency virus (HIV) infection and other virus-related immunodeficiency disorders. The invention comprises administering an anti-HIV effective amount of beta hCG to an asymptomatic individual with an HIV infection, including an individual presenting the symptoms of AIDS.Type: GrantFiled: August 22, 1995Date of Patent: September 22, 1998Assignee: Metatron, Inc.Inventor: Aldar S. Bourinbaiar
-
Patent number: 5552382Abstract: The invention relates to the use of gramicidin as an active ingredient of a spermicide with virucidal activity against human immunodeficiency virus (HIV)--a causative agent of a sexually transmitted disease--AIDS.Type: GrantFiled: December 2, 1994Date of Patent: September 3, 1996Assignee: Metatron, Inc.Inventor: Aldar S. Bourinbaiar
-
Patent number: 5541212Abstract: The invention relates to histamine H2-receptor antagonists such as cimetidine and related compounds such as ranitidine and famotidine that can be used for controlling human immunodeficiency virus (HIV) infection. The preferred agent is cimetidine. The invention comprises a method in vitro as well as in vivo for controlling, i.e., prevention and/or treatment, of HIV infection, associated with the development of acquired immune deficiency syndrome (AIDS), at pharmacological doses of these drugs commonly used for the treatment of gastrointestinal ulcers. The method is based on inhibiting HIV in vitro or on the administration to a host that has been exposed to HIV prior to diagnosis or has been diagnosed as having an HIV infection, of an amount of a H2 antagonist which is sufficient to exert an anti-HIV effect for a sufficient period of time.Type: GrantFiled: April 21, 1994Date of Patent: July 30, 1996Assignee: Metatron, Inc.Inventor: Aldar S. Bourinbaiar
-
Patent number: 4900341Abstract: The present invention relates to a fume purification system used in conjunction with food cooking equipment. The fumes which are generated during cooking pass through a plurality of filter balls washed by an oxidizing liquid which removes the greasy contaminants from the said fumes. A cooling coil is also used in conjunction with the filter balls to accelerate the condensation of the fumes. If required, a charcoal filter is placed before the purified air is returned to the atmosphere or recirculated in the system.Type: GrantFiled: June 29, 1988Date of Patent: February 13, 1990Assignee: Metatron Investments, Inc.Inventor: Julius S. Csabai